Diabetic Retinopathy: Micronutrient Therapy

A risk group indicates the possibility that the disease may be associated with the risk of vital substance (micronutrient) deficiency. The complaint diabetic retinopathy indicates a vital nutrient (micronutrient) deficiency for:

  • L-carnitine
  • Magnesium

The above vital substance recommendations (micronutrients) were created with the help of medical experts. All statements are supported by scientific publications with high levels of evidence. For a therapy recommendation, only clinical studies with the highest levels of evidence (grade 1a/1b and 2a/2b) were used, which due to their high significance prove the therapy recommendation. These data are updated at certain intervals.